Cystoid macular edema in the era of ocular hypotensive lipids

American Journal of Ophthalmology
M Wand, Bruce M Shields

Abstract

To review cystoid macular edema in relationship with ocular hypotensive lipids and to present recommendations for use in eyes at increased risk of cystoid macular edema. Focused literature review and authors' clinical experience. Cystoid macular edema in association with cataract surgery, epinephrine therapy, and ocular hypotensive lipid therapy is reviewed. Cystoid macular edema may be associated with a variety of therapeutic interventions, predominantly in eyes at increased risk with open or absent posterior lens capsule and ocular inflammation. Based primarily on experience with latanoprost, the association between ocular hypotensive lipids and cystoid macular edema, even in high-risk eyes, although present, appears to be low. Considering the low incidence of cystoid macular edema associated with latanoprost therapy, the authors feel that after maximal tolerable medical therapy and with proper precautions, the use of an ocular hypotensive lipid is an acceptable alternative to filtration surgery in high-risk eyes.

Associated Clinical Trials

References

Dec 15, 1978·Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie. Albrecht Von Graefe's Archive for Clinical and Experimental Ophthalmology·K MiyakeT Ozawa
Apr 1, 1978·Archives of Ophthalmology·J V ThomasJ V Lapus
Nov 1, 1976·The British Journal of Ophthalmology·T A MeredithS L Fine
Sep 1, 1975·American Journal of Ophthalmology·R G Michels, A E Maumenee
Apr 1, 1992·The British Journal of Ophthalmology·A PollackM Oliver
Jun 1, 1992·The British Journal of Ophthalmology·O NishiM Imanishi
Dec 1, 1990·Archives of Ophthalmology·K MiyakeE Shirasawa
Mar 1, 1990·Journal of Cataract and Refractive Surgery·C OhrloffM Spitznas
Oct 15, 1985·American Journal of Ophthalmology·T J LiesegangD M Ilstrup
May 1, 1968·Archives of Ophthalmology·A E Kolker, B Becker
May 1, 1984·Survey of Ophthalmology·L M JampolM C Kraff
Nov 1, 1982·[Zhonghua yan ke za zhi] Chinese journal of ophthalmology·Y H Sheng
Feb 1, 1997·Survey of Ophthalmology·D F WoodwardA Ocklind
Apr 29, 1998·Journal of the American Optometric Association·I B Gaddie, D W Bennett
Mar 8, 1996·Current Opinion in Ophthalmology·J Stjernschantz, A Alm
Nov 24, 1999·Journal of Cataract and Refractive Surgery·P G UrsellR B Nussenblatt
May 20, 2000·Journal of Cataract and Refractive Surgery·R J Mackool
Jun 10, 2000·Current Opinion in Ophthalmology·R A SchumerA K Mandahl
Sep 22, 2001·Journal of Cataract and Refractive Surgery·M WandM B Shields
Feb 28, 2002·American Journal of Ophthalmology·Martin Wand, Alexander R Gaudio
May 1, 1953·American Journal of Ophthalmology·S R IRVINE

❮ Previous
Next ❯

Citations

Oct 3, 2003·Journal of Cataract and Refractive Surgery·Kensaku MiyakeSampei Miyake
May 4, 2013·Drugs·Olga E MakriConstantine D Georgakopoulos
Dec 22, 2006·Expert Opinion on Drug Safety·Gábor Holló
Oct 22, 2008·Experimental Eye Research·Kathryn P B Cracknell, Ian Grierson
Nov 16, 2007·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Salomon Esquenazi
Nov 26, 2009·Expert Opinion on Pharmacotherapy·Ciro CostagliolaFrancesco Parmeggiani
Apr 17, 2003·Current Opinion in Ophthalmology·Camille Hylton, Alan L Robin
Nov 21, 2007·Annals of Ophthalmology·Faruk OztürkTuncay Küsbeci

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.